Odyssey Health, Inc. financial data

Symbol
ODYY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
2300 West Sahara Avenue, Suite 800 #4012, Las Vegas, NV
State of incorporation
NV
Fiscal year end
July 31
Former names
Odyssey Group International, Inc. (to 2/18/2022)
Latest financial report
10-Q - Q3 2024 - Dec 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.76 % -60.2%
Debt-to-equity -118 % +29.1%
Return On Equity -107 % -247%
Return On Assets -18.5 % +97.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.7M shares +16.3%
Common Stock, Shares, Outstanding 96.7M shares +18.3%
Entity Public Float 6.88M USD -37.5%
Common Stock, Value, Issued 96.7K USD +18.3%
Weighted Average Number of Shares Outstanding, Basic 105M shares +29.3%
Weighted Average Number of Shares Outstanding, Diluted 105M shares +29.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 0 USD -100%
General and Administrative Expense 1.53M USD -9.23%
Operating Income (Loss) 14M USD -67.1%
Net Income (Loss) Attributable to Parent -1.32M USD +69.3%
Earnings Per Share, Basic -0.01 USD/shares +80%
Earnings Per Share, Diluted -0.01 USD/shares +80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.9K USD -72.8%
Assets, Current 183K USD -67.6%
Property, Plant and Equipment, Net 0 USD -100%
Assets 341K USD -44.3%
Accounts Payable, Current 1.46M USD -21.3%
Accrued Liabilities, Current 13.8K USD 0%
Liabilities, Current 6.62M USD -3.08%
Liabilities 4.7M USD +95.7%
Retained Earnings (Accumulated Deficit) -62M USD -2.29%
Stockholders' Equity Attributable to Parent -6.28M USD -0.97%
Liabilities and Equity 341K USD -44.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -249K USD -315%
Net Cash Provided by (Used in) Financing Activities 300K USD +35.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.7M shares +18.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 53.9K USD -72.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 705 USD +28.4%
Deferred Tax Assets, Valuation Allowance 2.86M USD -3.31%
Deferred Tax Assets, Gross 2.86M USD -3.31%
Payments to Acquire Property, Plant, and Equipment 8.04K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 55.6M USD +2.41%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.54K USD -55%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 594K USD -6.16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%